$NXGL

Levy Adam R. sold $4K of NXGL

Levy Adam R. (Chief Executive Officer) sold 7,000 shares of NEXGEL, INC. (NXGL) at $0.61 on 2026-05-28.

Original reporting
SEC EDGAR · Levy Adam R.
Published May 30, 2026, 12:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 30, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NXGL
Bearish
medium confidence
Mentioned
$NXGL
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NXGLBearishLow
01

Why it matters

The disclosure updates insider ownership and may influence sentiment, but it does not introduce new operational or financial fundamentals by itself.

02

Market read

Traders may use the filing to gauge insider sentiment, but it is unlikely to drive a major repricing absent accompanying fundamental news.

03

What to watch

Check for other recent insider buys/sells, volume/price reaction around May 28, and whether any material corporate events occurred concurrently.

Relevance 6/10Novelty 6/10Timing: Filed May 29 for a sale executed May 28

Background

The article is an SEC Form 4 insider transaction disclosure for NEXGEL, Inc. (NXGL).

Company-level read

Ticker impact

$NXGLBearishMedium confidence
Context

NEXGEL CEO Levy Adam R. sold 7,000 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely small, short-lived impact at most; more relevant for monitoring insider activity trends than for a standalone trade.

Evidence & confidence

The filing is a routine insider transaction with no stated linkage to new company-specific events (e.g., trial, contract, guidance).

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide development.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity/tax needs; without a 10b5-1 plan stated, the sale still may be discretionary rather than bearish on fundamentals.

Key entities

  • NEXGEL, INC.

    Subject of the insider transaction disclosure (CEO sale).

  • Levy Adam R.

    Chief Executive Officer and director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NXGLLow

NEXGEL, INC. (NXGL): Results of Operations and Financial Condition

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content